Literature DB >> 6954972

Plasma fibronectin in acute leukaemia.

B J Boughton, A Simpson.   

Abstract

In acute leukaemia, low plasma fibronectin was seen at diagnosis and when the disease relapsed. This was not directly related to tumour load, chemotherapy or neutropenia, but correlated well with episodes of intercurrent infection. In severe infections, fibronectin fell rapidly to very low levels, and was sometimes not restored to normal up to 2 weeks later. Preliminary attempts at replacement therapy were successful and the possible importance of this is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6954972     DOI: 10.1111/j.1365-2141.1982.tb02806.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Technical method. Fresh frozen cryosupernatant in place of fresh frozen plasma for broad spectrum coagulation factor replacement.

Authors:  J A Napier; H Bass; R Pengilley
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

2.  Changes in plasma fibronectin during allogeneic bone marrow transplantation.

Authors:  D R Norfolk; M Bowen
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

3.  Plasma fibronectin concentrations in healthy and septic infants.

Authors:  M Domula; K Bykowska; Z Wegrzynowicz; S Lopaciuk; G Weissbach; M Kopéc
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

4.  Fibronectin and Kupffer cell function in fulminant hepatic failure.

Authors:  M Imawari; R D Hughes; C D Gove; R Williams
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

5.  Human fibronectin metabolism.

Authors:  B A Pussell; P W Peake; M A Brown; J A Charlesworth
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

Review 6.  Fibronectin and the critically ill patient: current status.

Authors:  T M Saba; J L Kiener; J M Holman
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

7.  Fibronectin in blood products--an in vitro and in vivo study.

Authors:  J T Reilly; B A McVerry; M J Mackie
Journal:  J Clin Pathol       Date:  1983-12       Impact factor: 3.411

8.  Cerebrospinal fluid concentration of fibronectin in patients with HIV-1 infection and central nervous system disorders.

Authors:  D Torre; C Zeroli; G Ferrario; G Bonetta; G P Fiori; R Martegani
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

9.  [Fibronectin].

Authors:  E Klar; D L Heene
Journal:  Klin Wochenschr       Date:  1984-10-15

10.  An experimental model for the study of the opsonic activity of fibronectin in the clearance of intravascular complexes.

Authors:  K W Walton; T J Almond; M Robinson; D L Scott
Journal:  Br J Exp Pathol       Date:  1984-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.